Of course looking back we all know what should have been done. Always easier than predicting the future.
But:
IMU got "blinded" by the IDMC recommendation ( 07/01/21 ) which, between the lines meant, hurry up and go straight into the rego trial. IMU was so surprised that LC said in the next interview something similar to " We are so surprised, we now need to decide what to do next. "
So they decided not to sell or to partner but to go ahead alone. Quite frankly, back then I supported that decision as I trusted LC's expertise. The new ph2 trial was designed to meet the FDA criteria and from there it went wrong big time.
What they plan now is anyone's guess thanks to IMU's 0%-transparency-strategy.
Selling / partnering? - So far ZERO success.
Putting on the shelf hoping for a future sale / deal? Probably, but how likely is that?
Throwing away, write off, despite what've been told how superior HER-Vaxx is over Herceptin?
The asset that was planned to be the start of the B-cell revolution, the one that shot IMU into the Billionsphere is now the one that symbolizes the companie's future: shelved, losing value day by day and failed business strategies. Everyone can catch $$$ when thrown by the market, but not many can pick them up when the times are a bit tougher.
One can only hope for holders that Hopper and LC learnt from their business mistakes and won't repeat them in case a partner emerges but by using CHM as an example that learning curve is still moving South.
And to those who accuse me of trying to drive the sp down, I won't touch it until something dramatic positive changes the outlook. Rather buy back for 10c with a certain positive future than at 1c following CHM's example.
The next way of funding will determine IMU's future:
A deal, that validates IMU as a serious player or
an ordinary Hopper - Raising that proves that the industry has ZERO interest in IMU's assets.
And to those who accuse me of promoting RAD, Have I been wrong? Hopper still chair but no power anymore - the change is proof for what is the only way to save IMU and CHM.
GLTA holders, you will need it.
- Forums
- ASX - By Stock
- Why IMU is a multi multi bagger
IMU
imugene limited
Add to My Watchlist
18.2%
!
1.3¢

Of course looking back we all know what should have been done....
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.3¢ |
Change
0.002(18.2%) |
Mkt cap ! $97.07M |
Open | High | Low | Value | Volume |
1.2¢ | 1.4¢ | 1.1¢ | $625.7K | 50.56M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
20 | 5795292 | 1.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.3¢ | 3258567 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
18 | 5735292 | 0.012 |
35 | 10497532 | 0.011 |
118 | 35980571 | 0.010 |
37 | 19431668 | 0.009 |
13 | 4220748 | 0.008 |
Price($) | Vol. | No. |
---|---|---|
0.013 | 3078567 | 8 |
0.014 | 10063029 | 39 |
0.015 | 6593187 | 20 |
0.016 | 6224494 | 27 |
0.017 | 7006978 | 10 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online